Of the about one-third receiving stimulant medication, 71.5% had difficulty filling prescription due to unavailability.

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts ...

HealthDay News — After Hurricane Helene knocked out a North Carolina production plant for a major supplier of IV fluids for US hospitals, officials said the federal government is reaching out ...

In subsequent dose-finding study, numerically greater reductions seen in fatigue, cognitive dysfunction scores with 40 to 45mg/day.

"The swing should never be used for sleep and bedding materials should never be added to it," according to an alert from the US Consumer Product Safety Commission, which announced the recall.